NNNN
Anbio Biotechnology - Class A (NNNN)
Healthcare • NASDAQ • $25.84-0.15%
- Symbol
- NNNN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $25.84
- Daily Change
- -0.15%
- Market Cap
- $1.13B
- Trailing P/E
- 172.27
- Forward P/E
- N/A
- 52W High
- $55.65
- 52W Low
- $6.40
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Company websiteResearch NNNN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.